SEDAR Interim Financial Statements

[
  {
    "companyName": "Adaptogenics Health Corp.",
    "reportingPeriodEnd": "2025-12-31",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cashAndCashEquivalents": 44154,
      "amountsReceivable": 3187,
      "prepaidExpenses": 0,
      "totalCurrentAssets": 47341,
      "totalAssets": 47341,
      "tradeAndOtherPayables": 25744,
      "totalCurrentLiabilities": 25744,
      "totalLiabilities": 25744,
      "shareCapital": 669886,
      "reserves": 15800,
      "deficit": -664089,
      "totalEquity": 21597,
      "totalLiabilitiesAndEquity": 47341,
      "cashPerShare": 0.0027,
      "workingCapitalPerShare": 0.0013
    },
    "incomeStatement": {
      "revenue": 0,
      "costOfSales": 0,
      "grossMargin": 0,
      "advertisingAndPromotions": 0,
      "filingFees": 14143,
      "generalAndAdministrative": 7618,
      "managementFees": 1500,
      "professionalFees": 15400,
      "shareBasedPayments": 0,
      "totalExpenses": 38661,
      "lossBeforeOtherItem": -38661,
      "interestIncome": 2594,
      "lossAndComprehensiveLoss": -36067,
      "weightedAverageSharesOutstandingBasic": 16397701,
      "weightedAverageSharesOutstandingDiluted": 16397701,
      "basicLossPerShare": 0,
      "dilutedLossPerShare": 0
    },
    "cashFlowStatement": {
      "lossForPeriod": -36067,
      "shareBasedPayments": 0,
      "changesInAmountsReceivable": 170,
      "changesInPrepaidExpenses": 575,
      "changesInTradeAndOtherPayables": -997,
      "netCashUsedInOperatingActivities": -36319,
      "changeInCashDuringPeriod": -36319,
      "cashAndCashEquivalentsBeginning": 80473,
      "cashAndCashEquivalentsEnd": 44154,
      "cash": 4154,
      "shortTermDeposits": 40000,
      "incomeTaxesPaid": 0,
      "interestPaidReceived": 0
    },
    "investmentsAndOtherAssets": [],
    "shareStructure": {
      "authorizedShares": "unlimited",
      "issuedShares": 16397701,
      "classesOfShares": ["Common Shares"],
      "warrants": [],
      "options": [
        {
          "number": 550000,
          "exercisePrice": 0.1,
          "expiryDate": "2026-08-15"
        }
      ],
      "rightsConvertibleInstruments": null
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "threeMonthsEndedDec312025": {
          "managementFees": 0,
          "shareBasedPayments": 0,
          "total": 0
        },
        "nineMonthsEndedDec312025": {
          "managementFees": 1500,
          "shareBasedPayments": 0,
          "total": 1500
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "MJJ Corporate Services Inc.",
          "description": "Management fees to company controlled by CFO",
          "amount": 1500,
          "period": "Nine-months ended December 31, 2025"
        }
      ]
    },
    "subsequentEvents": [
      {
        "eventDate": "2026-01-09",
        "description": "Release of 451,500 common shares from escrow",
        "impactValue": null
      }
    ]
  }
]